Sleep duration and association with cardiometabolic health in adolescents and adults with type 1 diabetes: Results from the BCQR-T1D study.
Stacey L SimonJanet K Snell-BergeonMichal SchäferAlex J BarkerLorna P BrowneUyen TruongShoshana S TellTimothy VigersAmy D BaumgartnerEllen LyonSarit PolskyIrene E SchauerKristen J NadeauPublished in: Diabetes, obesity & metabolism (2024)
Objectively measured sleep <7 h per night was prevalent in adolescents and adults with T1D and associated with poorer cardiometabolic health markers. Small changes in sleep were seen following BCQR treatment in adolescents only. Sleep may be an important and novel target for improving cardiometabolic health in individuals with T1D.